Prashant Trivedi - Concepedia

Concepedia

Author

Prashant Trivedi

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

P.C. Trivedi†,, Prashant Trivedi

10

Publications

1.2K

Citations

8

H-Index

28

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

PT

About

Prashant Trivedi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	242
2	Biochemistry	3	3	95
3	Natural Sciences	2	2	45
4	Health Sciences	1	1	77
5	Biomolecular Engineering	1	1	14

Prashant Trivedi

×

8

Publications

1.2K

Citations

8

H-Index

	Year	Citations
Distribution of orexin receptor mRNA in the rat brain Prashant Trivedi, Hong Yu, Douglas J. MacNeil, FEBS Letters	1998	983
The Antiobesity Effects of Centrally Administered Neuromedin U and Neuromedin S Are Mediated Predominantly by the Neuromedin U Receptor 2 (NMUR2) Andrea Peier, Jennifer Kosinski, Kimberly Cox‐York, Endocrinology Food IntakeObesityMetabolic SyndromeHypothalamic PeptideNeurology	2009	77
Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors Ashwin U. Rao, Dong Xiao, Xianhai Huang, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryHeterocyclicMedicineFacile Synthesis	2011	56
Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats Prashant Trivedi, Michael Jiang, Constantin Tamvakopoulos, Brain Research Gastrointestinal Peptide HormoneBiochemistryMedicinePhysiologyHypothalamic Peptide	2003	50
Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors Dong Xiao, Anandan Palani, Xianhai Huang, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBiochemistryNatural SciencesMedicine	2013	24
A three-step protocol for lead optimization: Quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors Xianhai Huang, Xiaohong Zhu, Wei Zhou, Bioorganic & Medicinal Chemistry Letters Molecular DockingThree-step ProtocolMedicinal ChemistryDrug TargetHit Identification	2011	21
Discovery of a novel series of potent MK2 non-ATP competitive inhibitors using 1,2-substituted azoles as cis-amide isosteres Dong Xiao, Xiaohong Zhu, Michael Sofolarides, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal Chemistry1,2-Substituted AzolesNovel SeriesMedicine	2014	14
BIOLOGICALLY POTENT HETEROCYCLIC SULPHONAMIDE IMINES AND THEIR MANGANESE (II) COMPLEXES Mukta Jain, Sampat Nehra†, Prashant Trivedi, Heterocyclic Communications	2003	10

Page 1